Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
876 hedge funds and large institutions have $52.1B invested in Allergan plc in 2020 Q1 according to their latest regulatory filings, with 82 funds opening new positions, 284 increasing their positions, 379 reducing their positions, and 152 closing their positions.
1% less funds holding in top 10
Funds holding in top 10: 112 → 111 (-1)
6% less capital invested
Capital invested by funds: $55.5B → $52.1B (-$3.41B)
8% less funds holding
Funds holding: 957 → 876 (-81)
25% less repeat investments, than reductions
Existing positions increased: 284 | Existing positions reduced: 379
46% less first-time investments, than exits
New positions opened: 82 | Existing positions closed: 152
80% less call options, than puts
Call options by funds: $259M | Put options by funds: $1.26B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$526M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$427M |
| 3 |
Renaissance Technologies
New York
|
+$390M |
| 4 |
Citigroup
New York
|
+$384M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$384M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Paulson & Co
New York
|
-$388M |
| 2 |
LP
Longview Partners
St Peter Port,
Guernsey
|
-$357M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$320M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$262M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$249M |
AGN Hedge Fund Activity: Q1 2020 in Review
876 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q1 2020, worth a combined $52.1B — down 6.1% from $55.5B a quarter earlier.
Sellers outnumbered buyers: 152 funds closed out of AGN and 82 opened new positions — a net loss of 70 holders — while 379 trimmed existing stakes and 284 added.
The largest buyer was Adage Capital Partners, adding an estimated $526M. The largest seller was Paulson & Co, cutting an estimated $388M.
- 876 institutional investors held Allergan plc (AGN) as of Q1 2020, down from 957 in Q4 2019.
- Funds reported $52.1B of Allergan plc stock for Q1 2020, down 6.1% quarter-over-quarter.
- 82 funds opened new Allergan plc positions in Q1 2020 and 152 closed out, a net change of -70 holders.
- The largest Allergan plc buyer in Q1 2020 was Adage Capital Partners, an estimated $526M added.
- The largest Allergan plc seller in Q1 2020 was Paulson & Co, an estimated $388M sold.
Based on aggregated 13F filings for Q1 2020.